World Cancer Leaders' Summit 2023

"Cancer control in a changing world" | 16-17 October 2023, Long Beach, CA, United States

View of Long Beach, California

Find out who won the awards

A celebration of outstanding work in advancing cancer control at UICC’s World Cancer Leaders’ Summit

Combined podium shot of award winners being congratulated on stage
Read more

The Cancer Institute NSW's eviQ program deserves recognition for its leadership in the field of cancer care. This state-wide government agency has made significant contributions to cancer care by providing freely accessible online cancer treatment protocols. These evidence-based guidelines have a global impact, with a diverse user base, including international healthcare professionals. EviQ's commitment to equity is evident through translation efforts, collaborations, and support for disadvantaged communities.

View full profile (PDF)

Liga contra el cancer in Peru has made a significant impact on cancer prevention, particularly among those with limited economic resources. They pioneered the "Population Screening" model through Mobile Units and Community Agent Networks. Their strong communication strategy has made them a national benchmark in cancer prevention. They've vaccinated schoolchildren, served millions of women, and conducted successful screening campaigns. Their commitment to equity is evident in providing free care, breaking socio-cultural barriers, and reaching vulnerable areas.

View full profile (PDF)

For over four decades, World Cancer Research Fund International (WCRFI) has pioneered research linking nutrition and cancer, producing influential reports and recommendations. Their efforts transcend borders, influencing national policies and reducing cancer risks. WCRFI prioritises equity by addressing health disparities and providing resources to disadvantaged communities. Their global recognition, official relations with WHO, and involvement in impactful initiatives solidify their leadership in cancer prevention research and advocacy.

View full profile (PDF)

Dr Freddie Bray is a leading figure at the International Agency for Research on Cancer (IARC), responsible for the Cancer Surveillance Section. He also leads the Global Initiative for Cancer Registration, an international multi-partner programme designed to ensure a sustainable expansion of the coverage and quality of population-based cancer registries in low- and middle- income countries. Dr Bray's unwavering commitment to data-driven policy saves lives and narrows cancer inequities at a large scale.

View full profile (PDF)

Dr Brenda Gallie is an internationally renowned ocular oncologist and the Head of the Retinoblastoma Program in the Hospital for Sick Children (Toronto). Her dedication to improving outcomes for children with retinoblastoma has transformed the field. She is known for her groundbreaking research, advocacy, innovative tools and compassionate care. Dr Gallie's commitment to equity is evident through her global efforts, bridging gaps in care and advocating for early detection, affordable treatment, and patient-centered research.

View full profile (PDF)

Dr David Poplack is a recognised leader in the field of pediatric oncology and served as Director of Texas Children’s Cancer Center for 25 years. Under his direction, the Center grew exponentially in faculty and impact. Dr Poplack is also the editor of a reference textbook in the field of pediatric oncology. His Global HOPE initiative with treatment and training centers in several African countries addresses alarming inequities and achieves significant improvements of survival rates.

View his full profile (PDF)


Background information

Entry criteria

All nominees must:

  • demonstrate that the individual's or organisation's work has contributed to making an outstanding contribution to cancer control, either through their research, advocacy, policy development, product development, patient support, clinical work or in another meaningful way;
  • be able to attend in person the award ceremony (or at least send a representative) at the World Cancer Leaders’ Summit on 17 October if their nomination is among the shortlisted finalists;
  • give consent for information about them to be featured on the UICC website and UICC social media channels;
  • give consent for potential media coverage of their nomination.

Organisation category:

  • Nominees must work for a UICC Full member organisation

Civil society category:

  • Nominees must work in the broader global health and/or cancer community, whether in an international organisation, academia, private sector or non-profit.

Judging criteria

Nominations will be judged on the following:

  • Has the nominee contributed to making an outstanding contribution to cancer control over the years, either through their research, advocacy, policy development, product development, patient support, clinical work or in another meaningful way?
  • Has the impact of their work extended, directly or indirectly, beyond a limited number of individuals or geographical area?
  • Has the nominee demonstrated a commitment to addressing inequity issues as part of their roles and achievements?
  • Is the nominee's story compelling, and does it inspire others to act?

The judging is organised in a two-tier process :

  • A shortlist of nominees will be evaluated and decided by a judging panel comprised of  UICC Board members and UICC past-Presidents selected by the current UICC President, Jeff Dunn. 
  • ​The winners in each category will be decided in a vote by UICC Full members


  • 14 July: Closing of the nominations period
  • 11 September: Shortlisted nominees announcement 
  • 25 September: Closing of the UICC Full members votes to decide the winners
  • 17 October: Winners announced at the World Cancer Leaders' Summit 2023